Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (KFO 214)
Deutsche Krebshilfe (111434, 70112975)
Deutsches Krebsforschungszentrum (DKFZ)
Received: 2 November 2020
Accepted: 18 March 2021
First Online: 31 March 2021
: All experiments were approved by the governmental review committee on animal care (G62/08 and G117/13).
: Not applicable.
: JD was financially supported by CRI -The Clinical Research Institute GmbH, View Ray Inc., Accuray International, Accuray Incorporated, RaySearch Laboratories AB, Vision RT limited, Merck Serono GmbH, Astellas Pharma GmbH, Astra Zeneca GmbH, Solution Akademie GmbH, Ergomed PLC Surrey Research Park, Siemens Healthcare GmbH, IQVIA RDS GmbH, Pharmaceutecal Research Associates GmbH, Boehringer Ingelheim Pharma GmbH Co, PTW-Freiburg Dr. Pychlau GmbH, and Nanobiotix A.A. All authors declare that they have no competing interests.